Literature DB >> 7642630

Regulation of phospholipase D by protein kinase C in human neutrophils. Conventional isoforms of protein kinase C phosphorylate a phospholipase D-related component in the plasma membrane.

I Lopez1, D J Burns, J D Lambeth.   

Abstract

In a variety of intact cells, phorbol esters are known to activate phospholipase D. In a cell-free system consisting of plasma membrane and cytosol from human neutrophils, phorbol esters activated phospholipase D in an adenosine nucleotide triphosphate-dependent manner. ATP gamma S (adenosine 5'-O-(thiotriphosphate)) was 2-3-fold more effective than ATP, while ADP and AppNHp (adenyl-5'-yl imidodiphosphate) were ineffective, and activation was blocked by the kinase inhibitor staurosporine. In cytosol deplete of protein kinase C by chromatography on threnoine-Sepharose, phorbol ester-dependent activation was lost, but was restored upon addition of purified rat brain protein kinase C. The target for phosphorylation was shown to be the plasma membrane plasma membrane was phosphorylated using ATP gamma S/phorbol 12,13-dibutyrate and protein kinase C and was reisolated to remove activators. Upon adding nucleotide-depleted cytosol, activator-independent phospholipase D activity was seen. Using this prephosphorylation protocol, PKC-dependent activation of plasma membranes was found to require micromolar calcium, implicating a conventional protein kinase C. Using recombinant isoforms of protein kinase C, only the conventional isoforms showed significant activation, with the following rank order of potency: beta 1 > alpha > gamma; the beta 2, delta, epsilon, eta, and sigma isoforms showed little or no activity. Thus, conventional isoform(s) of protein kinase C activate neutrophil phospholipase D by phosphorylating a target protein located in the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642630     DOI: 10.1074/jbc.270.33.19465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections.

Authors:  F A Saeed; G E Castle
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Overexpression of myristoylated alanine-rich C-kinase substrate enhances activation of phospholipase D by protein kinase C in SK-N-MC human neuroblastoma cells.

Authors:  S C Morash; S D Rosé; D M Byers; N D Ridgway; H W Cook
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells.

Authors:  N A Khan; A Hichami
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

4.  Effects of Clostridium difficile toxin A and toxin B on phospholipase D activation in human promyelocytic leukemic HL60 cells.

Authors:  K Ohguchi; Y Banno; S Nakashima; N Kato; K Watanabe; D M Lyerly; Y Nozawa
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.

Authors:  Marie-Hélène Paclet; Clare Davis; Peter Kotsonis; Jasminka Godovac-Zimmermann; Anthony W Segal; Lodewijk V Dekker
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

6.  Inhibition of formyl peptide-stimulated phospholipase D activation by Fal-002-2 via blockade of the Arf6, RhoA and protein kinase C signaling pathways in rat neutrophils.

Authors:  Ya-Ru Tsai; Li-Jiau Huang; Hui-Yi Lin; Yun-Jie Hung; Miau-Rong Lee; Sheng-Chu Kuo; Mei-Feng Hsu; Jih-Pyang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-23       Impact factor: 3.000

7.  Monosodium urate-crystal-stimulated phospholipase D in human neutrophils.

Authors:  J Marcil; D Harbour; M G Houle; P H Naccache; S Bourgoin
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

8.  The role of phospholipase D in osteoblast response to titanium surface microstructure.

Authors:  Mimi Fang; Rene Olivares-Navarrete; Marco Wieland; David L Cochran; Barbara D Boyan; Zvi Schwartz
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

9.  Tyrosine kinases and calcium dependent activation of endothelial cell phospholipase D by diperoxovanadate.

Authors:  V Natarajan; S Vepa; R Shamlal; M Al-Hassani; T Ramasarma; H N Ravishankar; W M Scribner
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

Review 10.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.